Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R)
Year: 2008
Type: article
Source: Investigational New Drugs
Institutions: University of Belgrade, Serbian Academy of Sciences and Arts
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W1969655042